Screener
IDNA vs PPH
iShares Genomics Immunology and Healthcare ETF vs VanEck Pharmaceutical ETF
Key differences
- PPH costs 0.11% less per year.
- PPH is significantly larger than IDNA — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PPH has delivered higher annualized returns.
- PPH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IDNA | PPH | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.36% |
| Fund size (AUM) | $160M | $966M |
| Since | 2019 | 2011 |
| Dividend yield | 1.05% | 2.12% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +50.4% | +24.2% |
| CAGR 3Y | +8.6% | +12.4% |
| CAGR 5Y | -7.2% | +9.9% |
| Sharpe 3Y | 0.31 | 0.61 |
| Volatility 1Y | 24.43% | 17.11% |
| Max drawdown | -68.26% | -29.70% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IDNA and PPH
Explore further